Skip to search.
 TSX Up 0.06% TSX Ventures Up 0.46%

Novavax, Inc. (NVAX)

-NasdaqGS
7.18 Up 0.31(4.51%) Aug 26, 4:00PM EDT
|After Hours : 7.22 Up 0.04 (0.56%) Aug 26, 7:59PM EDT
Prev Close:6.87
Open:7.20
Bid:7.12 x 2000
Ask:7.22 x 200
1y Target Est:14.49
Beta:1.66398
Earnings Date:Nov 7 - Nov 11 (Est.)
Day's Range:7.04 - 7.29
52wk Range:4.08 - 11.70
Volume:5,417,793
Avg Vol (3m):5,051,180
Market Cap:1.94B
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 4.51%1.94B
MRKUp 0.85%173.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):97.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.07
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback